ProfileGDS4459 / ENSG00000178035
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 82% 75% 90% 77% 83% 75% 84% 86% 86% 82% 77% 81% 88% 80% 83% 74% 73% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 16.1482
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 25.575
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 37.3190
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 45.6277
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 56.4683
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 65.6175
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 76.5484
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 86.8186
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 96.9386
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 106.3882
GSM623474group B, liver allograft wedge biopsie placebo treatment 15.8277
GSM623475group B, liver allograft wedge biopsie placebo treatment 26.3881
GSM623476group B, liver allograft wedge biopsie placebo treatment 36.9888
GSM623477group B, liver allograft wedge biopsie placebo treatment 45.8680
GSM623478group B, liver allograft wedge biopsie placebo treatment 56.5783
GSM623479group B, liver allograft wedge biopsie placebo treatment 65.4274
GSM623480group B, liver allograft wedge biopsie placebo treatment 75.4273